Eli Lilly Lowers Weight-Loss Drug Zepbound Prices After Trump Deal [Forbes]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Forbes
14% decrease from $349, while the 5-milligram dose was cut to $399, a roughly 20% cut from $499, Eli Lilly announced Prices for the 7.5 through 15 milligram doses were reduced to $449 from $499. Novo Nordisk announced last month the out-of-pocket monthly price of Ozempic and Wegovy would be lowered to $349 from $499, and that the two lowest doses of either drug would be available for $199 per month for the first two months. Eli Lilly's shares fell nearly 1% in premarket trading after the announcement, while Novo Nordisk's stock traded down more than 1.7%. $1,086. That's the monthly cost of Zepbound before any discounts or rebates, according to Eli Lilly. The list price for Ozempic is just over $997 per month.
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- As Eli Lilly Cuts Zepbound Prices, Should You Buy, Sell, or Hold LLY Stock? [Yahoo! Finance]Yahoo! Finance
- Eli Lilly and Company (NYSE:LLY) was upgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "hold (c+)" rating to a "buy (b-)" rating.MarketBeat
- Eli Lilly and Company (LLY): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Eli Lilly and Company (NYSE:LLY) was given a new $1,200.00 price target on by analysts at BMO Capital Markets.MarketBeat
- Companies Cut Prices For Blockbuster Weight-Loss Drugs [Forbes]Forbes
LLY
Earnings
- 10/30/25 - Beat
LLY
Sec Filings
- 11/26/25 - Form 4
- 11/26/25 - Form 4
- 11/25/25 - Form 4
- LLY's page on the SEC website